According to Vifor Pharma's latest financial reports the company has $1.08 B in cash and cash equivalents.
A companyโs cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.
Year | Cash on Hand | Change |
---|---|---|
2021-12-31 | $1.08 B | 30.54% |
2020-12-31 | $0.83 B | 48.09% |
2019-12-31 | $0.56 B | 38.23% |
2018-12-31 | $0.40 B | -6.78% |
2017-12-31 | $0.43 B | 142.95% |
2016-12-31 | $0.17 B | -57.97% |
2015-12-31 | $0.42 B | 77.2% |
2014-12-31 | $0.24 B | -0.85% |
2013-12-31 | $0.24 B | -37.46% |
2012-12-31 | $0.38 B | 5.73% |
2011-12-31 | $0.36 B | 14.87% |
2010-12-31 | $0.32 B | 398.26% |
2009-12-31 | $64.3 M | -29.58% |
2008-12-31 | $91.31 M | 89.48% |
2007-12-31 | $48.19 M | -48.46% |
2006-12-31 | $93.5 M | 214.69% |
2005-12-31 | $29.71 M | -34.26% |
2004-12-31 | $45.19 M | -48.87% |
2003-12-31 | $88.4 M | -20.47% |
2002-12-31 | $0.11 B |